节点文献
新活素治疗急性心力衰竭临床观察
Clinical observation of lyophilized recombinant human brain natriuretic peptide for acute heart failure
【摘要】 目的观察冻干重组人脑利钠肽(新活素)治疗急性心力衰竭(AHF)的临床疗效。方法100例AHF患者随机分为新活素组与硝酸甘油组各50例,2组均给予常规治疗,新活素组在常规治疗基础上加用新活素,硝酸甘油组加用硝酸甘油,观察2组疗效及肺毛细血管楔嵌压(PCWP)、肺动脉压(PAP)的变化。结果新活素组总有效率为96%高于对照组的64%,差异有统计学意义(P<0.05)。新活素组给药后第1、3、6小时的PCWP、PAP降低值高于硝酸甘油组,差异均有统计学意义(P<0.05)。结论新活素治疗AHF临床疗效确切,值得临床推广应用。
【Abstract】 Objective To study the effficacy of lyophilized recombinant human brain natriuretic peptide(rh-BNP)for treating acute heart failure.Methods 100 patients with acute heart failure were randomly divided into rh-BNP group(n=50)and nitroglycerin group(n=50).The two groups were given conventional treatment,the rh-BNP group on the basis of conventional therapy with rh-BNP added.Observed the efficacy of two group pressure and pulmonary capillary wedge(PCWP),pulmonary artery pressure(PAP)changed.Results The total effective rate of rh-BNP group was 96%,higher than 64% of the nitroglycerin group,the difference was statistically significant(P<0.05).The rh-BNP group 1,3,6 hours after administration of PCWP,PAP reduced were lower than nitroglycerin group,the differences were statistically significant(P<0.05).ConclusionThe rh-BNP of the clinical efficacy of treatment of AHF is accurate,and worthy of clinical application.
- 【文献出处】 临床合理用药杂志 ,Chinese Journal of Clinical Rational Drug Use , 编辑部邮箱 ,2010年06期
- 【分类号】R541.6
- 【被引频次】36
- 【下载频次】632